114 related articles for article (PubMed ID: 11353644)
1. In vitro activities of DU-1102, a new trioxaquine derivative, against Plasmodium falciparum isolates.
Basco LK; Dechy-Cabaret O; Ndounga M; Meche FS; Robert A; Meunier B
Antimicrob Agents Chemother; 2001 Jun; 45(6):1886-8. PubMed ID: 11353644
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and antimalarial activity of trioxaquine derivatives.
Dechy-Cabaret O; Benoit-Vical F; Loup C; Robert A; Gornitzka H; Bonhoure A; Vial H; Magnaval JF; Séguéla JP; Meunier B
Chemistry; 2004 Apr; 10(7):1625-36. PubMed ID: 15054749
[TBL] [Abstract][Full Text] [Related]
3. In vitro activities of piperaquine and other 4-aminoquinolines against clinical isolates of Plasmodium falciparum in Cameroon.
Basco LK; Ringwald P
Antimicrob Agents Chemother; 2003 Apr; 47(4):1391-4. PubMed ID: 12654675
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of ferroquine (SAR97193) is independent of chloroquine resistance in Plasmodium falciparum.
Kreidenweiss A; Kremsner PG; Dietz K; Mordmüller B
Am J Trop Med Hyg; 2006 Dec; 75(6):1178-81. PubMed ID: 17172389
[TBL] [Abstract][Full Text] [Related]
5. Trioxaquines are new antimalarial agents active on all erythrocytic forms, including gametocytes.
Benoit-Vical F; Lelièvre J; Berry A; Deymier C; Dechy-Cabaret O; Cazelles J; Loup C; Robert A; Magnaval JF; Meunier B
Antimicrob Agents Chemother; 2007 Apr; 51(4):1463-72. PubMed ID: 17242150
[TBL] [Abstract][Full Text] [Related]
6. 3-Iodo-4-aminoquinoline derivative sensitises resistant strains of Plasmodium falciparum to chloroquine.
Edaye S; Tazoo D; Bohle DS; Georges E
Int J Antimicrob Agents; 2016 Jun; 47(6):482-5. PubMed ID: 27211211
[TBL] [Abstract][Full Text] [Related]
7. Selection of a trioxaquine as an antimalarial drug candidate.
Coslédan F; Fraisse L; Pellet A; Guillou F; Mordmüller B; Kremsner PG; Moreno A; Mazier D; Maffrand JP; Meunier B
Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17579-84. PubMed ID: 18987321
[TBL] [Abstract][Full Text] [Related]
8. Preparation and antimalarial activities of "trioxaquines", new modular molecules with a trioxane skeleton linked to a 4-aminoquinoline.
Dechy-Cabaret O; Benoit-Vical F; Robert A; Meunier B
Chembiochem; 2000 Nov; 1(4):281-3. PubMed ID: 11828420
[No Abstract] [Full Text] [Related]
9. The chemotherapy of rodent malaria, XXXVIII. Studies on the activity of three new antimalarials (WR 194,965, WR 228,258 and WR 225,448) against rodent and human malaria parasites (Plasmodium berghei and P. falciparum).
Peters W; Irare SG; Ellis DS; Warhurst DC; Robinson BL
Ann Trop Med Parasitol; 1984 Dec; 78(6):567-79. PubMed ID: 6398032
[TBL] [Abstract][Full Text] [Related]
10. 4-Aminoquinoline quinolizidinyl- and quinolizidinylalkyl-derivatives with antimalarial activity.
Sparatore A; Basilico N; Parapini S; Romeo S; Novelli F; Sparatore F; Taramelli D
Bioorg Med Chem; 2005 Sep; 13(18):5338-45. PubMed ID: 16054368
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum sensitivity to erythromycin and 4-aminoquinoline combinations in vitro.
Khan B; Brandling-Bennett AD; Watkins WM; Oloo AJ; Ojoo P; Koech DK
Ann Trop Med Parasitol; 1991 Apr; 85(2):215-22. PubMed ID: 1796864
[TBL] [Abstract][Full Text] [Related]
12. 4-aminoquinoline analogs of chloroquine with shortened side chains retain activity against chloroquine-resistant Plasmodium falciparum.
Ridley RG; Hofheinz W; Matile H; Jaquet C; Dorn A; Masciadri R; Jolidon S; Richter WF; Guenzi A; Girometta MA; Urwyler H; Huber W; Thaithong S; Peters W
Antimicrob Agents Chemother; 1996 Aug; 40(8):1846-54. PubMed ID: 8843292
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of antimalarial activity of chloramphenicol against Indian Plasmodium falciparum isolates in vitro by chloroquine.
Biswas S
Indian J Malariol; 2002; 39(1-2):26-33. PubMed ID: 14686107
[TBL] [Abstract][Full Text] [Related]
14. Dichlorquinazine (alpha 4-aminoquinoline) effective in vitro against chloroquine-resistant Plasmodium falciparum.
Le Bras J; Deloron P; Charmot G
Lancet; 1983 Jan; 1(8314-5):73-4. PubMed ID: 6129409
[No Abstract] [Full Text] [Related]
15. 4-Aminoquinoline resistance of Plasmodium falciparum: insights from the study of amodiaquine uptake.
Bray PG; Hawley SR; Ward SA
Mol Pharmacol; 1996 Dec; 50(6):1551-8. PubMed ID: 8967977
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and bioevaluation of novel 4-aminoquinoline-tetrazole derivatives as potent antimalarial agents.
Pandey S; Agarwal P; Srivastava K; Rajakumar S; Puri SK; Verma P; Saxena JK; Sharma A; Lal J; Chauhan PM
Eur J Med Chem; 2013 Aug; 66():69-81. PubMed ID: 23792317
[TBL] [Abstract][Full Text] [Related]
17. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
[TBL] [Abstract][Full Text] [Related]
18. Antiplasmodial activity of new 4-aminoquinoline derivatives against chloroquine resistant strain.
Sinha M; Dola VR; Agarwal P; Srivastava K; Haq W; Puri SK; Katti SB
Bioorg Med Chem; 2014 Jul; 22(14):3573-86. PubMed ID: 24906512
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, characterization, and antiplasmodial activity of polymer-incorporated aminoquinolines.
Aderibigbe BA; Neuse EW; Sadiku ER; Ray SS; Smith PJ
J Biomed Mater Res A; 2014 Jun; 102(6):1941-9. PubMed ID: 23853120
[TBL] [Abstract][Full Text] [Related]
20. Synthesis, Docking, In Vitro and In Vivo Antimalarial Activity of Hybrid 4-aminoquinoline-1,3,5-triazine Derivatives Against Wild and Mutant Malaria Parasites.
Bhat HR; Singh UP; Gahtori P; Ghosh SK; Gogoi K; Prakash A; Singh RK
Chem Biol Drug Des; 2015 Sep; 86(3):265-71. PubMed ID: 25487527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
